# Trade Mark Journal No.2026/023 5 June 2026

## UK00004361774 25 March 2026 (35,41,42)

Mark 1

Mark 2

Class 35
  Business consultancy & advisory services; Business consultancy and advisory services in the field of healthcare and pharmaceuticals; Advisory services relating to medicines optimisation and healthcare system efficiency; Business management advisory services; Organisation of business networking and collaborative forums in the healthcare sector; Business networking; Business Consulting; Strategic business advisory services relating to healthcare system sustainability.
Class 41
  Education, training, seminars & conferences; Organisation and conducting of conferences, seminars, workshops and roundtable discussions in the field of healthcare and medicines optimisation; Organising of conferences, seminars and workshops; Educational services relating to medicines optimisation and healthcare system improvement; Publication of reports, white papers and research papers in the field of healthcare and pharmaceuticals; Providing online forums in the field of medicines optimisation; Organising of education conferences.
Class 42
  Scientific research; Scientific research and analysis; Scientific research and development; Research and analysis in the field of healthcare policy and medicines optimisation; Scientific analysis; Medical research; Technical data analysis; Evidence led analysis and structured research; Preparation of technical reports; Preparation of scientific reports; Preparation of technical reports relating to pharmaceuticals and healthcare systems.

ASPIRE PHARMA LIMITED

Representative: Howes Percival LLP